- Home
- JGH vs LFMD Comparison
JGH vs LFMD Comparison
Compare JGH & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JGH | LFMD |
|---|---|---|
| Founded | 2014 | 1994 |
| Country | United States | United States |
| Employees | N/A | 384 |
| Industry | Investment Managers | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 285.5M | 190.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | JGH | LFMD |
|---|---|---|
| Price | $12.40 | $3.42 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $9.14 |
| AVG Volume (30 Days) | 79.8K | ★ 1.3M |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | ★ 9.85% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $16.11 |
| Revenue Next Year | N/A | $20.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.22 | $2.60 |
| 52 Week High | $13.70 | $15.34 |
Technical Indicators
Market Signals| Indicator | JGH | LFMD |
|---|---|---|
| Relative Strength Index (RSI) | 50.51 | 43.81 |
| Support Level | $12.38 | $2.66 |
| Resistance Level | $12.94 | $4.19 |
| Average True Range (ATR) | 0.18 | 0.25 |
| MACD | 0.04 | -0.08 |
| Stochastic Oscillator | 77.56 | 9.02 |
Price Performance
Historical ComparisonAbout JGH Nuveen Global High Income Fund of Beneficial Interest
Nuveen Global High Income Fund operates as a diversified closed-end management investment company. Its investment objective is to provide a high level of current income. The Fund's securities include U.S. high-yield bonds; non-U.S. high-yield bonds from developed and emerging markets; and other income-producing investments such as preferred and convertible securities.
About LFMD LifeMD Inc.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.